National Lung Cancer Partnership- Lung Cancer Mutation Consortium
The purpose of this study is to determine the frequency of mutations in 1000 patients with advanced lung cancer
Advanced lung cancer
1. Subjects 18 years or older who are undergoing further evaluation for the diagnosis or treatment of advanced carcinoma of the lung.
2. Participants must have a SWOG performance status of 0-2.
1. Lack of adequate tissue
18 - 100
Healthy Volunteers Needed
Duration of Participation
Andrea Burt, RN (503-494-5601)
National Lung Cancer Partnership; Lung Cancer Mutation Consortium